{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:21:46Z","timestamp":1787610106441,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300669"],"award-info":[{"award-number":["82300669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["202004j07020044"],"award-info":[{"award-number":["202004j07020044"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["YJS20240020"],"award-info":[{"award-number":["YJS20240020"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023xkjT039"],"award-info":[{"award-number":["2023xkjT039"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117070","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:59:49Z","timestamp":1782561589000},"page":"117070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dynamic monitoring of circulating tumor cells and PD-L1 combined positive score as prognostic biomarkers for adjuvant immunochemotherapy in stage III gastric cancer: A prospective observational study"],"prefix":"10.1016","volume":"186","author":[{"given":"Xiaoyu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziting","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangsheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117070_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.117070_bb0010","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.intimp.2026.117070_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bjc.6601896","article-title":"Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view","volume":"91","author":"Lim","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117070_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.sla.0000152019.14741.97","article-title":"Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study","volume":"241","author":"Marrelli","year":"2005","journal-title":"Ann. Surg."},{"key":"10.1016\/j.intimp.2026.117070_bb0025","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117070_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","article-title":"Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial","volume":"379","author":"Bang","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117070_bb0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial","volume":"15","author":"Noh","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2026.117070_bb0040","first-page":"2166","article-title":"Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer","volume":"58","author":"Li","year":"2011","journal-title":"Hepato-gastroenterology."},{"key":"10.1016\/j.intimp.2026.117070_bb0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015014360","article-title":"Advances in molecular biomarkers for gastric cancer","volume":"25","author":"Zheng","year":"2015","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.intimp.2026.117070_bb0050","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature20785","article-title":"Early dissemination seeds metastasis in breast cancer","volume":"540","author":"Hosseini","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117070_bb0055","doi-asserted-by":"crossref","first-page":"13564","DOI":"10.1074\/jbc.M307688200","article-title":"Up-regulation of vascular endothelial growth factor-a by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases","volume":"279","author":"Sounni","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117070_bb0060","doi-asserted-by":"crossref","first-page":"81558","DOI":"10.18632\/oncotarget.18277","article-title":"Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: mechanisms and clinical applications","volume":"8","author":"Jie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2026.117070_bb0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Yu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117070_bb0070","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117070_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00384-018-03223-9","article-title":"Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients","volume":"34","author":"Wang","year":"2019","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.intimp.2026.117070_bb0080","article-title":"Clinical utility of circulating tumor cells in patients with esophageal cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117070_bb0085","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cyto.a.23669","article-title":"Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting","volume":"93","author":"Fehm","year":"2018","journal-title":"Cytometry A"},{"key":"10.1016\/j.intimp.2026.117070_bb0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/SLA.0000000000001341","article-title":"Metastatic spread emerging from liver metastases of colorectal cancer: does the seed leave the soil again?","volume":"263","author":"Rahbari","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.intimp.2026.117070_bb0095","article-title":"Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2026.117070_bb0100","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2024.28463","article-title":"First-line Sugemalimab plus chemotherapy for advanced gastric Cancer: the GEMSTONE-303 randomized clinical trial","volume":"333","author":"Zhang","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2026.117070_bb0105","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2023.19918","article-title":"Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trial","volume":"330","author":"Xu","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2026.117070_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117070_bb0115","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2026.117070_bb0120","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41591-024-03450-4","article-title":"First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial","volume":"31","author":"Shen","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117070_bb0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S2468-1253(24)00156-0","volume":"9","author":"Kang","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.117070_bb0130","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/JTO.0000000000000606","article-title":"Folate receptor\u2013positive circulating tumor cell detected by LT-PCR\u2013based method as a diagnostic biomarker for non\u2013small-cell lung cancer","volume":"10","author":"Chen","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.intimp.2026.117070_bb0135","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.31557\/APJCP.2025.26.7.2687","article-title":"Optimization and validation of a folate ligand-targeted qPCR method for detection of folate receptor-positive circulating tumor cells in gastric Cancer","volume":"26","author":"Suwa","year":"2025","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.intimp.2026.117070_bb0140","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.5301\/jbm.5000151","article-title":"Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer","volume":"30","author":"Lee","year":"2015","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.intimp.2026.117070_bb0145","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1245\/s10434-015-4483-6","article-title":"Circulating tumor cells as an independent predictor of survival in advanced gastric cancer","volume":"22","author":"Okabe","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.intimp.2026.117070_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-024-01637-3","article-title":"Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"17","key":"10.1016\/j.intimp.2026.117070_bb0155","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.3390\/ijms26178637","article-title":"Comprehensive analysis of SIGLEC-15 and PD-L1 expression identifies distinct prognostic profiles in gastric Cancer","volume":"26","author":"Cozac-Sz\u0151ke","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:53:52Z","timestamp":1786323232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S1567576926009161"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117070","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic monitoring of circulating tumor cells and PD-L1 combined positive score as prognostic biomarkers for adjuvant immunochemotherapy in stage III gastric cancer: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117070"}}